In silico analysis of the conservation of human toxicity and endocrine disruption targets in aquatic species.
about
Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetineLeveraging existing data for prioritization of the ecological risks of human and veterinary pharmaceuticals to aquatic organisms.Assessing variation in the potential susceptibility of fish to pharmaceuticals, considering evolutionary differences in their physiology and ecologyComparative pharmacology and toxicology of pharmaceuticals in the environment: diphenhydramine protection of diazinon toxicity in Danio rerio but not Daphnia magnaAdverse outcome pathway development II: best practices.Applying evolutionary genetics to developmental toxicology and risk assessment.Pharmaceuticals and personal care products: A critical review of the impacts on fish reproduction.Widespread occurrence and potential for biodegradation of bioactive contaminants in Congaree National Park, USA.Predicted and observed therapeutic dose exceedances of ionizable pharmaceuticals in fish plasma from urban coastal systems.Changing tides: Adaptive monitoring, assessment, and management of pharmaceutical hazards in the environment through time.Docking to multiple pockets or ligand fields for screening, activity prediction and scaffold hopping.Editor's Highlight: Sequence Alignment to Predict Across Species Susceptibility (SeqAPASS): A Web-Based Tool for Addressing the Challenges of Cross-Species Extrapolation of Chemical Toxicity.Evaluation of the scientific underpinnings for identifying estrogenic chemicals in nonmammalian taxa using mammalian test systems.Comparing the sensitivity of chlorophytes, cyanobacteria, and diatoms to major-use antibiotics.Analysis of drug binding pockets and repurposing opportunities for twelve essential enzymes of ESKAPE pathogensOrphan receptor ligand discovery by pickpocketing pharmacological neighbors.Allosteric binding sites in Rab11 for potential drug candidates.Urbanization, environment and pharmaceuticals: advancing comparative physiology, pharmacology and toxicology
P2860
Q28543995-850B5A9A-37E2-4153-BE73-EF40176E19AEQ30870407-6730EC2E-A026-4C3C-BD0F-A3EF553D8540Q34423526-D05D5461-0D9A-44D6-B528-16BA4881099BQ34871672-843D16EB-D5B3-41F6-A9E3-488FAFF3210FQ35055209-7580BDB1-570F-46DF-B172-043D2C539D32Q36299276-52C0B435-2548-431F-BF4C-4ED3DC2949E0Q38461963-25BDB35C-6C6C-4FE8-9B1E-8A9FB3198B0DQ38557360-212F5F28-D8DA-4298-9780-39723F4AFB4DQ38891637-D86729AB-BE49-4C0D-9209-C511DCB0ED7EQ38959413-6EDA9098-5CF2-4AA3-8289-1065235599D5Q39096521-FC7A98DE-A188-47F7-BB38-39B107935914Q39637745-A00C7143-D081-4C7A-8561-D703E323C5B2Q39854165-4AEEC68B-870F-4205-BA1D-6BD0DD67071BQ39909226-ED20688A-02C5-4CFE-8592-CFDB49D4FFEFQ41694518-95F94606-7AC8-4CC2-8501-B8AF8868E436Q42112336-F6B06445-1907-4BAE-9C1D-348AD966C602Q55281306-115F3739-34C6-481A-848F-D546166982AFQ58577220-07D5873E-ABD7-4D6B-9D15-45C97BA9DB89
P2860
In silico analysis of the conservation of human toxicity and endocrine disruption targets in aquatic species.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
In silico analysis of the cons ...... on targets in aquatic species.
@en
type
label
In silico analysis of the cons ...... on targets in aquatic species.
@en
prefLabel
In silico analysis of the cons ...... on targets in aquatic species.
@en
P2860
P356
P1476
In silico analysis of the cons ...... on targets in aquatic species.
@en
P2093
Fiona M McRobb
Virginia Sahagún
P2860
P304
P356
10.1021/ES404568A
P407
P577
2014-01-15T00:00:00Z